Insider Transactions in Q1 2022 at Evelo Biosciences, Inc. (EVLO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
David R Epstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,926
+3.89%
|
-
|
|
Feb 28
2022
|
David R Epstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,926
+4.22%
|
-
|
|
Jan 31
2022
|
Mark D. Plinio Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+50.0%
|
$5,000
$4.0 P/Share
|
|
Jan 31
2022
|
David R Epstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,925
+4.61%
|
-
|